It is a research & development private limited company based in Hyderabad, Telangana, India, established in 2013.
2013 | Hyderabad, Telangana, India | ActiveTranstox Bioapplications Private Limited, a active private limited company, was established on 17 December 2013 in Hyderabad, Telangana, India. Engaging in science research within the research & development sector, it holds CIN: U73100TG2013PTC091742. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a active non-compliant status. Its leadership includes Rajesh Kumar Thengal Ganesh (Director), Surya Emani (Director), Ravi Cherukuri (Director). Past directors included Subhadra Dravida. Its latest AGM occurred on 27 September 2017, with the balance sheet filed on 31 March 2017. It is based at 11-11-129/1/2 Road No. 3 Sowbhagya Puram Colony, Hyderabad, Telangana, 500038.
U73100TG2013PTC091742
091742
17 December 2013
₹0.10 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Transtox Bioapplications Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Kumar Thengal Ganesh | Director | 17 Dec 2013 | Current |
| Surya Emani | Director | 01 Feb 2014 | Current |
| Ravi Cherukuri | Director | 17 Dec 2013 | Current |
| Subhadra Dravida | Director | 01 Feb 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Transtox Bioapplications Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2017, Transtox Bioapplications had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Transtox Bioapplications, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Transtox Bioapplications, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Transtox Bioapplications's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Transtox Bioapplications Private Limited last Annual general meeting of members was held on 27 Sep 2017 as per latest MCA records. was recorded as a recent event.
Progress on Transtox Bioapplications Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was documented.
The activity Surya Emani was appointed as a Director was appointed as a Director on 01 Feb 2014 & has been associated with this company since 11 years 9 months . was completed.
The activity Subhadra Dravida was appointed as a Director was appointed as a Director on 01 Feb 2014 & has been associated with this company since 11 years 9 months . was completed.
Rajesh Kumar Thengal Ganesh was appointed as a Director was appointed as a Director on 17 Dec 2013 & has been associated with this company since 11 years 11 months . was recorded as a recent event.
The activity Ravi Cherukuri was appointed as a Director was appointed as a Director on 17 Dec 2013 & has been associated with this company since 11 years 11 months . was completed.
The CIN of Transtox Bioapplications Private Limited is U73100TG2013PTC091742.
Transtox Bioapplications Private Limited is headquartered at 11-11-129/1/2 Road No. 3 Sowbhagya Puram Colony, Hyderabad, Telangana, 500038.
Transtox Bioapplications Private Limited was incorporated on 17 December 2013.
The current directors of Transtox Bioapplications Private Limited are
The primary industry of Transtox Bioapplications Private Limited is Research & Development.
Transtox Bioapplications Private Limited is unlisted.
The authorized capital of Transtox Bioapplications Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Transtox Bioapplications Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX